Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 445

1.

Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake.

Zhou F, Yao HH, Wu JY, Yang YJ, Ding JH, Zhang J, Hu G.

J Neurosci Res. 2006 Aug 1;84(2):268-77.

PMID:
16752416
2.
3.
4.

Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia.

Yoshioka H, Sugita M, Kinouchi H.

Neurosci Lett. 2009 Sep 25;461(3):266-70. doi: 10.1016/j.neulet.2009.06.056. Epub 2009 Jun 21.

PMID:
19549561
5.

Activator protein-1 responsive to the group II metabotropic glutamate receptor subtype in association with intracellular calcium in cultured rat cortical neurons.

Sugiyama C, Nakamichi N, Ogura M, Honda E, Maeda S, Taniura H, Yoneda Y.

Neurochem Int. 2007 Dec;51(8):467-75. Epub 2007 May 10.

PMID:
17559977
6.

Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury.

Fei Z, Zhang X, Bai HM, Jiang XF, Wang XL.

J Clin Neurosci. 2006 Dec;13(10):1023-7.

PMID:
17113985
8.

mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons.

Lafon-Cazal M, Fagni L, Guiraud MJ, Mary S, Lerner-Natoli M, Pin JP, Shigemoto R, Bockaert J.

Eur J Neurosci. 1999 Feb;11(2):663-72.

PMID:
10051767
9.
10.
11.
12.
13.

DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury.

Venero JL, Santiago M, Tomás-Camardiel M, Matarredona ER, Cano J, Machado A.

Neuroscience. 2002;113(4):857-69.

PMID:
12182892
14.

The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling.

Bruno V, Sureda FX, Storto M, Casabona G, Caruso A, Knopfel T, Kuhn R, Nicoletti F.

J Neurosci. 1997 Mar 15;17(6):1891-7.

15.
16.

(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.

Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ.

J Pharmacol Exp Ther. 1999 Jun;289(3):1678-87.

17.

Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death.

Bruno V, Battaglia G, Ksiazek I, van der Putten H, Catania MV, Giuffrida R, Lukic S, Leonhardt T, Inderbitzin W, Gasparini F, Kuhn R, Hampson DR, Nicoletti F, Flor PJ.

J Neurosci. 2000 Sep 1;20(17):6413-20.

19.

Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration.

Bruno V, Battaglia G, Copani A, Giffard RG, Raciti G, Raffaele R, Shinozaki H, Nicoletti F.

Eur J Neurosci. 1995 Sep 1;7(9):1906-13.

PMID:
8528465
20.

L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.

Kirschstein T, von der Brelie C, Steinhäuser M, Vinçon A, Beck H, Dietrich D.

Neuropharmacology. 2004 Aug;47(2):157-62.

PMID:
15223294

Supplemental Content

Support Center